Cardiovascular safety in refractory incontinent patients with overactive bladder receiving add-on mirabegron therapy to solifenacin (BESIDE)

  1. Drake, M.J.
  2. MacDiarmid, S.
  3. Chapple, C.R.
  4. Esen, A.
  5. Athanasiou, S.
  6. Cambronero Santos, J.
  7. Mitcheson, D.
  8. Herschorn, S.
  9. Siddiqui, E.
  10. Huang, M.
  11. Stoelzel, M.
Revista:
International Journal of Clinical Practice

ISSN: 1742-1241,  1368-5031

Any de publicació: 2017

Volum: 71

Número: 5

Tipus: Article

DOI: 10.1111/IJCP.12944 GOOGLE SCHOLAR lock_openAccés obert editor
Font de les dades: Scopus